InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,189.60
(
0.11%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.31
(
0.22%
)
Bitcoin
66,123.99
(
-0.77%
)
Post# of 252218
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

cooldrinkh2o

Send PM Follow Ignore
Followers 0
Posts 113
Boards Moderated 0
Alias Born 05/28/2005

cooldrinkh2o

Re: bladerunner1717 post# 78099

Monday, 05/18/2009 12:15:41 PM

Monday, May 18, 2009 12:15:41 PM

Post# of 252218
One potential problem with the data is that the majority of the patients did not receive SOC (Chop+R) as 1st line therapy.

Another could be the use of maintanence R after 1st line.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up